v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 3,519 $ 4,353
Accounts receivable, net of allowance for credit loss reserve, $21 and $10 as of March 31, 2026 and December 31, 2025, respectively 818 857
Note receivable, net of allowance for credit loss reserve, $12 and $12 as of March 31, 2026 and December 31, 2025, respectively 1,988 1,988
Unbilled revenue 285 338
Prepaid expenses and other current assets 208 154
Inventory 31 37
TOTAL CURRENT ASSETS 6,849 7,727
PROPERTY AND EQUIPMENT, NET 16 20
INTANGIBLE ASSETS, NET 2,325 2,345
GOODWILL 2,926 2,926
TOTAL ASSETS 12,116 13,018
CURRENT LIABILITIES    
Accounts payable 532 745
Other accrued expense 457 530
Convertible note – related party, current 400 400
Convertible note, current 350 350
TOTAL CURRENT LIABILITIES 1,739 2,025
TOTAL LIABILITIES 1,739 2,025
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value; 675,000,000 shares authorized; 13,581,242 and 13,553,049 shares issued, 13,119,065 and 13,071,601  shares outstanding as of March 31, 2026 and December 31, 2025, respectively 14 14
Additional paid in capital 102,096 102,059
Treasury stock at cost; 462,117 and 481,448 shares at March 31, 2026 and December 31, 2025, respectively (476) (502)
Accumulated deficit (91,257) (90,578)
STOCKHOLDERS' EQUITY 10,377 10,993
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 12,116 13,018
Series A Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock
Series B Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock